The Economic Contribution of Pharmaceutical Marketing

Journal of Pharmaceutical Marketing and Management

Volumn 14, Issue 42067, 2002, Pages 101-108

  Kolassa, E M ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

competition; cost effectiveness; Pharmaceutical marketing; pharmaceutical promotion; physician learning

Indexed keywords

EID: 33847658817     PISSN: 08837597     EISSN: 15408574     Source Type: Journal    
DOI: 10.3109/J058v14n03_07     Document Type: Article

References (16)

1. Drake D, Uhlman M. Making medicine, making money. Kansas City: Andrews and McMeel; 1993.
2. Fagan SC, et al. Cost-effectiveness of Tissues Plasminogen Activator for acute ischemic stroke. Neurol. 1998; 50: 883 – 9.
3. Legg RF, et.al. Cost benefit of sumatriptan to an employer. J Occup Environ Med. 1997; 39: 652 – 7.
4. Peters WP. Comparative effects of G-CSF and PBPC chemotherapy. Blood. 1993; 81: 1709 – 19.
5. Anon. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991; 325: 293 – 302.
6. Boston Consulting Group. The contribution of pharmaceutical companies: What's at stake for America? Boston: Boston Consulting Group; 1993.
7. Battelle Medical Policy Assessment and Research Center. The value of pharma-ceuticals: An assessment of future costs for selected conditions. Washington, DC: Battelle Human Affairs Research Centers (MEDTAP); 1991.
8. Berndt E. Illness and productivity: Objective workplace evidence. MIT Working Paper; May 1997.
9. Payne JW, Beaman JR, Johnson EJ. The adaptive decision maker. Cambridge, MA: Cambridge University Press; 1993.
10. Fennell ML, Warnecke RB. The diffusion of medical innovation: An applied network analysis. New York: Plenum Press; 1988.
11. Avorn J, Harvey K, Soumerai SB, Herxheimer A, Plumridge R, Bardelay G. In-formation and education as determinants of antibiotic use: Report of Task Force 5. Res Infectious Dis. 1987; 9 (3): 5286 – 96.
12. Schwartzman D. Innovation in the pharmaceutical industry. Baltimore: Johns Hopkins University Press; 1976.
13. Kolassa EM. Growing competition in the pharmaceutical industry: A response to the PRIME Institute Report—An academic critique of the PRIME Institute Report, Competition and Pricing Issues in the Pharmaceutical Market. University, MS: Uni-versity of Mississippi Research Institute of Pharmaceutical Sciences; 1995.
14. Davis DA, Fox RD, eds. The physician as learner: Linking research to practice. Chicago: American Medical Association; 1994.
15. Boston Consulting Group. The changing environment for U.S. pharmaceut-icals: The role of pharmaceutical companies in a systems approach to health care: a re-port. New York: Boston Consulting Group; 1993.
16. Nagle TT, Holden RK. The strategy and tactics of pricing. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall; 1995.